PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

Overview of attention for article published in Nature Medicine, June 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 48 news outlets
blogs: 2 blogs

twitter: 63 X users
facebook: 1 Facebook page

Readers on

mendeley: 9 Mendeley

Summary News Blogs X Facebook

So far, Altmetric has seen 2 posts from 2 blogs.

PSCA-CAR T Cell Therapy in Metastatic Castration-Resistant Prostate Cancer: A Phase I Trial

Stemcell science news, 13 Jun 2024

Scientists reported results from a Phase II, first-in-human study of prostate stem cell antigen (PSCA)-directed CAR T cells in…

CAR T cell therapy for advanced prostate cancer demonstrates positive results in Phase I clinical trial

Health Medicine Network, 12 Jun 2024

Patient with biochemical and radiographic response with associated immune landscape changes. Credit: Nature Medicine (2024). DOI…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.